Healthcare - Biotechnology - NASDAQ - US
$ 35.94
-2.97 %
$ 2.79 B
Market Cap
-276.46
P/E
CASH FLOW STATEMENT
44.2 M
OPERATING CASH FLOW
15.1 M
INVESTING CASH FLOW
2.84 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Veracyte, Inc.
| Net Income | -74.4 M |
| Depreciation & Amortization | 27.2 M |
| Capital Expenditures | -9.96 M |
| Stock-Based Compensation | 33.1 M |
| Change in Working Capital | -4.16 M |
| Others | 60.1 M |
| Free Cash Flow | 34.3 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||
| Net Income | (74.4) | (36.6) | (75.6) | (34.9) | (12.6) | (23.0) | (31.0) | (31.4) | (33.7) | (29.4) | (25.6) | (18.6) | (14.4) |
| Depreciation & Amortization | 27.2 | 25.9 | 19.6 | 7.9 | 4.1 | 3.9 | 3.8 | 3.5 | 2.3 | 1.2 | 1.0 | 0.7 | 0.6 |
| Deferred Income Tax | (3.8) | 0.1 | (6.3) | 2.1 | 23 K | 0 | 12 K | 80 K | 0.1 | 54 K | 0.2 | 0.2 | 0.5 |
| Stock Based Compensation | 33.1 | 26.7 | 22.5 | 13.0 | 9.8 | 6.0 | 6.6 | 6.4 | 5.6 | 3.5 | 1.2 | 0.9 | 0.7 |
| Other Operating Activities | 66.3 | 7.7 | 3.9 | 2.7 | 0.3 | 0.3 | 2.1 | (0.2) | (1.8) | (2.1) | (0.3) | (2.7) | (0.7) |
| Change in Working Capital | (4.2) | (16.4) | 4.2 | (0.5) | (4.8) | (0.7) | (5.4) | (6.4) | 0.6 | (0.9) | 4.3 | 12.3 | 80 K |
| Cash From Operations | 44.2 | 7.5 | (31.6) | (9.7) | (3.2) | (13.5) | (23.9) | (28.0) | (27.0) | (27.6) | (19.2) | (7.2) | (13.5) |
| INVESTING CASH FLOW | |||||||||||||
| Capital Expenditures | (10.0) | (8.5) | (5.4) | (2.8) | (2.8) | (1.9) | (1.8) | (4.2) | (6.2) | (2.0) | (1.3) | (1.5) | (0.3) |
| Other Items | 25.1 | (20.8) | (733.8) | (1.0) | (40.0) | 0 | 0.6 | 2 K | (0.5) | (7.0) | 50 K | 0 | 55 K |
| Cash From Investing Activities | 15.1 | (29.4) | (739.2) | (3.8) | (42.7) | (1.9) | (1.2) | (4.2) | (6.7) | (9.0) | (1.3) | (1.5) | (0.3) |
| FINANCING CASH FLOW | |||||||||||||
| Common Stock Repurchased | (6.7) | (3.2) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.1) | 0 | 0 | 0 |
| Total Debt Repaid | 0 | (1.3) | 0 | 100 K | (25.2) | (0.3) | (2.3) | 19.2 | 0 | (0.1) | 4.9 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.8 | 4.8 | 2.5 | 9.9 | 14.6 | 4.8 | 1.9 | 1.2 | 0.5 | 0.5 | 6.5 | 15.1 | 18.6 |
| Cash From Financing Activities | 2.8 | 3.5 | 596.3 | 203.6 | 127.3 | 59.5 | (0.2) | 52.3 | 37.7 | 0.4 | 77.7 | 15.1 | 18.6 |
| CHANGE IN CASH | |||||||||||||
| Net Change In Cash | 62.3 | (18.9) | (176.0) | 190.0 | 81.3 | 44.1 | (25.3) | 20.1 | 4.1 | (36.2) | 57.2 | 6.4 | 4.8 |
| FREE CASH FLOW | |||||||||||||
| Free Cash Flow | 34.3 | (1.0) | (37.0) | (12.5) | (6.0) | (15.4) | (25.7) | (32.2) | (33.1) | (29.7) | (20.5) | (8.6) | (13.8) |